![]() |
|
| Department of Radiology, Brigham and Women's Hospital Harvard Medical School |
The goal of this NIH-funded project is to improve the acquisition, reconstruction, and extraction of quantitative information from Ga-67 SPECT data, and to assess these improvements to the imaging system using task-dependent criteria. Gallium-67 has proven to be a useful nuclear medicinal tracer for imaging certain tumors, and it is known that gallium's avidity in non-Hodgkin's lymphoma is correlated with histopathologic tumor grade.
It is expected that the imaging system improvements will lead to more accurate staging of lymphoma and, consequently, improved patient care due to enhanced capability to follow the progession of the disease, choose the best treatment, and monitor the response to therapy.
See About BrighamRAD for information about this Web site.
Is this a mirrored page?
The official URL is http://brighamrad.harvard.edu/research/topics/nucmed/moore.html
Contact the BrighamRAD design team at radweb@dsg.harvard.edu